Distinct Clinical and Experimental Characteristics in the Patients Younger than 60 Years Old with Myelodysplastic Syndromes

by Li, Xiao, Xiao, Zhi-jian, Chang, Chun-kang, Xu, Feng, Wu, Ling-yun, He, Qi, Xu, Ze-feng, Song, Lu-xi, Zhang, Zheng, Zhou, Li-yu, Su, Ji-ying, Zhang, Xi, Guo, Juan
Published 2013

Establishment and Validation of an Updated Diagnostic FCM Scoring System Based on Pooled Immunophenotyping in CD34+ Blasts and Its Clinical Significance for Myelodysplastic Syndrom...

by Xu, Feng, Li, Xiao, Chang, Chun-Kang, Guo, Juan, Wu, Ling-Yun, He, Qi, Zhang, Zheng, Zhu, Yang, Gu, Shu-Chen, Shi, Wen-Hui, Song, Lu-Xi, Su, Ji-Ying, Zhou, Li-Yu, Zhang, Xi, Wu, Dong
Published 2014

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes

by Xu, Feng, Wu, Ling-Yun, Chang, Chun-Kang, He, Qi, Zhang, Zheng, Liu, Li, Shi, Wen-Hui, Guo, Juan, Zhu, Yang, Zhao, You-Shan, Gu, Shu-Cheng, Fei, Cheng-Ming, Wu, Dong, Zhou, Li-Yu, Su, Ji-Ying, Song, Lu-Xi, Xiao, Chao, Li, Xiao
Published 2015